Instil Bio, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 12.93 million compared to USD 53.84 million a year ago. Basic loss per share from continuing operations was USD 1.99 compared to USD 8.29 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.6 USD | +1.92% | -0.38% | +39.11% |
Apr. 15 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 12 | Jefferies Downgrades Instil Bio to Hold From Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.11% | 68.94M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- TIL Stock
- News Instil Bio, Inc.
- Instil Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023